Atlas Trials

Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects

Clinical trial NCT02467842 · COMPLETED

Trial details

NCT number
NCT02467842
Sponsor
SK Chemicals Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza
Start date
2014-10-01
Primary completion
2014-12-01
Enrollment
1503

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.